Physicochemical Properties
| Molecular Formula | C6H8B2O4 |
| Molecular Weight | 165.75 |
| Exact Mass | 166.06 |
| CAS # | 4612-26-4 |
| Related CAS # | 676566-94-2 |
| PubChem CID | 230478 |
| Appearance | White to off-white solid powder |
| Density | 1.3±0.1 g/cm3 |
| Boiling Point | 420.1±55.0 °C at 760 mmHg |
| Melting Point | >350 °C(lit.) |
| Flash Point | 207.9±31.5 °C |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.555 |
| LogP | 0.96 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Heavy Atom Count | 12 |
| Complexity | 118 |
| Defined Atom Stereocenter Count | 0 |
| SMILES | C1=C(C=CC(=C1)B(O)O)B(O)O |
| InChi Key | BODYVHJTUHHINQ-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C6H8B2O4/c9-7(10)5-1-2-6(4-3-5)8(11)12/h1-4,9-12H |
| Chemical Name | (4-boronophenyl)boronic acid |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | 1,4-Phenylenediboronic acid is employed in Suzuki-Miyaura cross-coupling reactions, scholl cyclizations, and palladium-catalyzed sequential alkenylation and conjugate addition reactions. Additionally, it is employed in the production of derivatives of indolizide, including organic thin-film transistors, OLEDs, solution-processable coordination polymers, and F-fluorescence. |
Solubility Data
| Solubility (In Vitro) | DMSO: 100 mg/mL (603.32 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (15.08 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (15.08 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 3: ≥ 2.5 mg/mL (15.08 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.0332 mL | 30.1659 mL | 60.3318 mL | |
| 5 mM | 1.2066 mL | 6.0332 mL | 12.0664 mL | |
| 10 mM | 0.6033 mL | 3.0166 mL | 6.0332 mL |